41.71 USD
+0.71 (+1.73%)
41.71 USD
0 (0%)
We assign a fundamental rating of 5 out of 10 to PDEX. PDEX was compared to 187 industry peers in the Health Care Equipment & Supplies industry. While PDEX belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. PDEX has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
PDEX had positive earnings in the past year.
PDEX had a negative operating cash flow in the past year.
In the past 5 years PDEX has always been profitable.
In multiple years PDEX reported negative operating cash flow during the last 5 years.
1.2 Ratios
PDEX has a Return On Assets of 17.41%. This is amongst the best in the industry. PDEX outperforms 98.40% of its industry peers.
With an excellent Return On Equity value of 26.96%, PDEX belongs to the best of the industry, outperforming 97.86% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 16.51%, PDEX belongs to the top of the industry, outperforming 96.26% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for PDEX is significantly above the industry average of 8.81%.
The last Return On Invested Capital (16.51%) for PDEX is above the 3 year average (14.16%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.41% | ||
| ROE | 26.96% | ||
| ROIC | 16.51% |
ROA(3y)10.79%
ROA(5y)11.4%
ROE(3y)17.93%
ROE(5y)20.5%
ROIC(3y)14.16%
ROIC(5y)12.68%
1.3 Margins
PDEX's Profit Margin of 15.94% is amongst the best of the industry. PDEX outperforms 91.98% of its industry peers.
In the last couple of years the Profit Margin of PDEX has declined.
The Operating Margin of PDEX (15.36%) is better than 83.96% of its industry peers.
PDEX's Operating Margin has declined in the last couple of years.
PDEX has a worse Gross Margin (28.09%) than 78.07% of its industry peers.
PDEX's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.36% | ||
| PM (TTM) | 15.94% | ||
| GM | 28.09% |
OM growth 3Y9.36%
OM growth 5Y-4.56%
PM growth 3Y7.44%
PM growth 5Y-5.13%
GM growth 3Y-2.11%
GM growth 5Y-4.93%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so PDEX is creating value.
The number of shares outstanding for PDEX has been reduced compared to 1 year ago.
PDEX has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, PDEX has a worse debt to assets ratio.
2.2 Solvency
PDEX has an Altman-Z score of 6.74. This indicates that PDEX is financially healthy and has little risk of bankruptcy at the moment.
PDEX's Altman-Z score of 6.74 is amongst the best of the industry. PDEX outperforms 84.49% of its industry peers.
PDEX has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
PDEX has a Debt to Equity ratio of 0.21. This is comparable to the rest of the industry: PDEX outperforms 58.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 6.74 |
ROIC/WACC1.96
WACC8.43%
2.3 Liquidity
PDEX has a Current Ratio of 3.73. This indicates that PDEX is financially healthy and has no problem in meeting its short term obligations.
PDEX has a better Current ratio (3.73) than 64.71% of its industry peers.
A Quick Ratio of 2.14 indicates that PDEX has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.14, PDEX is in line with its industry, outperforming 56.15% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.73 | ||
| Quick Ratio | 2.14 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 107.14% over the past year.
Measured over the past years, PDEX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.96% on average per year.
PDEX shows a strong growth in Revenue. In the last year, the Revenue has grown by 23.65%.
PDEX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.84% yearly.
EPS 1Y (TTM)107.14%
EPS 3Y35.1%
EPS 5Y10.96%
EPS Q2Q%86.67%
Revenue 1Y (TTM)23.65%
Revenue growth 3Y16.57%
Revenue growth 5Y13.84%
Sales Q2Q%24.43%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-4.43%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.48%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 13.08 indicates a correct valuation of PDEX.
90.37% of the companies in the same industry are more expensive than PDEX, based on the Price/Earnings ratio.
PDEX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.28.
With a Price/Forward Earnings ratio of 17.18, PDEX is valued on the expensive side.
PDEX's Price/Forward Earnings ratio is rather cheap when compared to the industry. PDEX is cheaper than 83.96% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.52, PDEX is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.08 | ||
| Fwd PE | 17.18 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, PDEX is valued cheaper than 89.30% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 10.5 |
4.3 Compensation for Growth
The decent profitability rating of PDEX may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.19
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
PDEX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
41.71
+0.71 (+1.73%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners31.87%
Inst Owner Change-3.05%
Ins Owners36.03%
Ins Owner Change1.64%
Market Cap135.97M
Revenue(TTM)70.23M
Net Income(TTM)11.19M
Analysts82.86
Price Target57.12 (36.95%)
Short Float %10.08%
Short Ratio3.86
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)74.8%
Min EPS beat(2)-24.91%
Max EPS beat(2)174.51%
EPS beat(4)3
Avg EPS beat(4)69.51%
Min EPS beat(4)-24.91%
Max EPS beat(4)174.51%
EPS beat(8)5
Avg EPS beat(8)44.11%
EPS beat(12)7
Avg EPS beat(12)20.2%
EPS beat(16)8
Avg EPS beat(16)16.17%
Revenue beat(2)1
Avg Revenue beat(2)7.28%
Min Revenue beat(2)-4.18%
Max Revenue beat(2)18.74%
Revenue beat(4)2
Avg Revenue beat(4)7.58%
Min Revenue beat(4)-4.18%
Max Revenue beat(4)19.3%
Revenue beat(8)6
Avg Revenue beat(8)12.93%
Revenue beat(12)9
Avg Revenue beat(12)11.32%
Revenue beat(16)12
Avg Revenue beat(16)11.48%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.08 | ||
| Fwd PE | 17.18 | ||
| P/S | 1.94 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 3.28 | ||
| P/tB | 3.28 | ||
| EV/EBITDA | 10.5 |
EPS(TTM)3.19
EY7.65%
EPS(NY)2.43
Fwd EY5.82%
FCF(TTM)-0.67
FCFYN/A
OCF(TTM)-0.39
OCFYN/A
SpS21.54
BVpS12.73
TBVpS12.73
PEG (NY)N/A
PEG (5Y)1.19
Graham Number30.23
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.41% | ||
| ROE | 26.96% | ||
| ROCE | 21.27% | ||
| ROIC | 16.51% | ||
| ROICexc | 20.85% | ||
| ROICexgc | 20.86% | ||
| OM | 15.36% | ||
| PM (TTM) | 15.94% | ||
| GM | 28.09% | ||
| FCFM | N/A |
ROA(3y)10.79%
ROA(5y)11.4%
ROE(3y)17.93%
ROE(5y)20.5%
ROIC(3y)14.16%
ROIC(5y)12.68%
ROICexc(3y)16.6%
ROICexc(5y)14.6%
ROICexgc(3y)16.62%
ROICexgc(5y)14.63%
ROCE(3y)18.25%
ROCE(5y)16.34%
ROICexgc growth 3Y23.73%
ROICexgc growth 5Y-8.41%
ROICexc growth 3Y23.84%
ROICexc growth 5Y-8.25%
OM growth 3Y9.36%
OM growth 5Y-4.56%
PM growth 3Y7.44%
PM growth 5Y-5.13%
GM growth 3Y-2.11%
GM growth 5Y-4.93%
F-Score6
Asset Turnover1.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.72 | ||
| Cap/Depr | 73.12% | ||
| Cap/Sales | 1.3% | ||
| Interest Coverage | 12.57 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.73 | ||
| Quick Ratio | 2.14 | ||
| Altman-Z | 6.74 |
F-Score6
WACC8.43%
ROIC/WACC1.96
Cap/Depr(3y)99.37%
Cap/Depr(5y)344.26%
Cap/Sales(3y)1.93%
Cap/Sales(5y)6.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)107.14%
EPS 3Y35.1%
EPS 5Y10.96%
EPS Q2Q%86.67%
EPS Next Y-4.43%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)23.65%
Revenue growth 3Y16.57%
Revenue growth 5Y13.84%
Sales Q2Q%24.43%
Revenue Next Year4.48%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y29.16%
EBIT growth 3Y27.48%
EBIT growth 5Y8.65%
EBIT Next Year10.43%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-206.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-142.63%
OCF growth 3YN/A
OCF growth 5YN/A
PRO-DEX INC / PDEX FAQ
Can you provide the ChartMill fundamental rating for PRO-DEX INC?
ChartMill assigns a fundamental rating of 5 / 10 to PDEX.
Can you provide the valuation status for PRO-DEX INC?
ChartMill assigns a valuation rating of 5 / 10 to PRO-DEX INC (PDEX). This can be considered as Fairly Valued.
Can you provide the profitability details for PRO-DEX INC?
PRO-DEX INC (PDEX) has a profitability rating of 7 / 10.
Can you provide the expected EPS growth for PDEX stock?
The Earnings per Share (EPS) of PRO-DEX INC (PDEX) is expected to decline by -4.43% in the next year.